Evaluation of Safety and Efficiency of Metreleptin Treatment for Patients With Multiple Symmetric Lipomatosis (MSL)

NCT05351164 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Lipomatosis, Multiple Symmetrical

Interventions

DRUG: Metreleptin

Sponsor

University of Michigan

Collaborators

[object Object]